ResearcherPeking University First HospitalNo recent work listed
Di Long
Matched on ORCID iD 0000-0001-5082-2772; OpenAlex author ID A5084053599. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2021: 1 paper · 2022: 2 papers
Papers 3
- Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215834↗
- MicroRNAs as potential therapeutic targets for pancreatic cancer. Co-author DOI 10.1097/cm9.0000000000001826↗
- Unfolded protein response activated by endoplasmic reticulum stress in pancreatic cancer: potential therapeutical target. Co-author DOI 10.52586/5061↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaodong Tian · 3 shared papers, 2021–2022 · strength 0.54
- Paper Unfolded protein response activated by endoplasmic reticulum stress in pancreatic cancer: potential therapeutical targe… DOI 10.52586/5061↗
- Paper MicroRNAs as potential therapeutic targets for pancreatic cancer. DOI 10.1097/cm9.0000000000001826↗
- Paper Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic can… DOI 10.1016/j.canlet.2022.215834↗
- Yinmo Yang · 1 shared paper, 2021 · strength 0.19
- Yinmo Yang · 1 shared paper, 2022 · strength 0.19
- Xiangyu Chu · 1 shared paper, 2022 · strength 0.19
- Yinmo Yang · 1 shared paper, 2022 · strength 0.16
- Kai Chen · 1 shared paper, 2022 · strength 0.16
- Yazhou Wang · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.